Publications by the researcher in collaboration with Ana Rouzaut Subirá (17)

2022

  1. Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

    Cancer research, Vol. 82, Núm. 23, pp. 4373-4385

  2. Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers

    Theranostics, Vol. 12, Núm. 3, pp. 1373-1387

2021

  1. Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophils

    European Journal of Immunology, Vol. 51, Núm. 9, pp. 2274-2280

2020

  1. CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity

    Immunity, Vol. 52, Núm. 5, pp. 856-871.e8

2018

  1. ICAM-1-LFA-1 dependent CD8+ T-lymphocyte aggregation in tumor tissue prevents recirculation to draining lymph nodes

    Frontiers in Immunology, Vol. 9, Núm. SEP

  2. Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation

    Cancer Immunology Research, Vol. 6, Núm. 7, pp. 798-811

2017

  1. Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule Are Induced by Ionizing Radiation on Lymphatic Endothelium

    International Journal of Radiation Oncology Biology Physics, Vol. 97, Núm. 2, pp. 389-400

  2. T Cell Migration from Inflamed Skin to Draining Lymph Nodes Requires Intralymphatic Crawling Supported by ICAM-1/LFA-1 Interactions

    Cell Reports, Vol. 18, Núm. 4, pp. 857-865

2013

  1. Initial afferent lymphatic vessels controlling outbound leukocyte traffic from skin to lymph nodes

    Frontiers in Immunology, Vol. 4, Núm. DEC

  2. Lymphatic endothelium forms integrin-engaging 3d structures during DC transit across inflamed lymphatic vessels

    Journal of Investigative Dermatology, Vol. 133, Núm. 9, pp. 2276-2285

  3. Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC

    International Journal of Cancer, Vol. 132, Núm. 9, pp. 1986-1995

2012

  1. CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of dendritic cells

    FASEB Journal, Vol. 26, Núm. 8, pp. 3380-3392

  2. The HIF-1α hypoxia response in tumor-infi ltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy

    Cancer Discovery, Vol. 2, Núm. 7, pp. 608-623

2011

  1. Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes

    Cancer Research, Vol. 71, Núm. 3, pp. 801-811

  2. Intratumoral injection of interferon-α and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy

    International Journal of Cancer, Vol. 128, Núm. 1, pp. 105-118

2010

  1. Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-α

    European Journal of Immunology, Vol. 40, Núm. 11, pp. 3054-3063

  2. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: A molecular insight into the importance of quitting smoking during treatment

    Toxicological Sciences, Vol. 116, Núm. 2, pp. 467-476